Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ · Healthcare
Biomarin Pharmaceutical Inc. Gross Profit 2008–2025
Biomarin Pharmaceutical Inc. annual/quarterly gross profit history and growth rate from 2008 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Biomarin Pharmaceutical Inc. gross profit for the quarter ending March 31, 2026 was 571.2 M, a 3.77% decrease year-over-year.
- Biomarin Pharmaceutical Inc. gross profit for the twelve months ending March 31, 2026 was 2.5 B, a 17.03% increase year-over-year.
- Biomarin Pharmaceutical Inc. annual gross profit for 2025 was 2.5 B, a 10.12% increase from 2024.
- Biomarin Pharmaceutical Inc. annual gross profit for 2024 was 2.3 B, a 20.48% increase from 2023.
- Biomarin Pharmaceutical Inc. annual gross profit for 2023 was 1.9 B, a 18.46% increase from 2022.
- Biomarin Pharmaceutical Inc. annual gross profit for 2022 was 1.6 B.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Biomarin Pharmaceutical Inc. Gross Profit — FAQ
Biomarin Pharmaceutical Inc. (BMRN) gross profit over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Biomarin Pharmaceutical Inc.'s gross profit?
Biomarin Pharmaceutical Inc. (BMRN) reported gross profit of $2.50B for fiscal 2025.
Where can I see BMRN's gross profit history?
The chart and table above show Biomarin Pharmaceutical Inc.'s gross profit by year and by quarter, including the growth rate.